Evidence map›Paper›PMID 31734995›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2019

[Study of tumor necrosis factor receptor superfamily 1B gene polymorphism in relation to the outcomes of HCV infection].

P Zhu, M Yue, Q Chen, M Yao, J J Wu, J G Shao, H Xue, Y Zhang, P Huang, C H Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

P ZhuMedical Department, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
M YueDepartment of Infectious Diseases, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Q ChenEastern Theater Command Centers for Disease Control and Prevention, Nanjing 210002, China.
M YaoDepartment of Immunology, Medical School of Nantong University, Nantong 226001, China.
J J WuDepartment of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing 211166, China.
J G ShaoDepartment of Gastroenterology, the Nantong Third Affiliated Hospital of Nantong University, Nantong 226001, China.
H XueFourth Ward, the Nantong Third Affiliated Hospital of Nantong University, Nantong 226001, China.
Y ZhangEastern Theater Command Centers for Disease Control and Prevention, Nanjing 210002, China; Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing 211166, China.
P HuangDepartment of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing 211166, China.
C H WangEastern Theater Command Centers for Disease Control and Prevention, Nanjing 210002, China.

Funding

National Natural Science Foundation of China 81773499, 81703273Natural Science Foundation of Jiangsu Province BK20171054Open Research Fund Program of the State Key Laboratory of Virology of China 2019KF005
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Genetic Predisposition to DiseaseGenotypeHaplotypesHepatitis CHumansPolymorphism, Single NucleotideReceptors, Tumor Necrosis Factor, Type IIReceptors, Tumor Necrosis Factor, Type IITNFRSF1B protein, humanChronicityGene polymorphismHepatitis C virusTumor necrosis factor receptor superfamily member 1B

Identifiers

PMID31734995
PMCPMC12770057

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.